Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2001

01-05-2001

Elevated Serum Homocysteine levels and Increased risk of Invasive Cervical Cancer in US Women

Authors: Stephanie J. Weinstein, Regina G. Ziegler, Jacob Selhub, Thomas R. Fears, Howard D. Strickler, Louise A. Brinton, Richard F. Hamman, Robert S. Levine, Katherine Mallin, Paul D. Stolley

Published in: Cancer Causes & Control | Issue 4/2001

Login to get access
Metadata
Title
Elevated Serum Homocysteine levels and Increased risk of Invasive Cervical Cancer in US Women
Authors
Stephanie J. Weinstein
Regina G. Ziegler
Jacob Selhub
Thomas R. Fears
Howard D. Strickler
Louise A. Brinton
Richard F. Hamman
Robert S. Levine
Katherine Mallin
Paul D. Stolley
Publication date
01-05-2001
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2001
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1011290103779

Other articles of this Issue 4/2001

Cancer Causes & Control 4/2001 Go to the issue

OriginalPaper

Association of Family History and Other risk factors with Breast Cancer Risk among Japanese Premenopausal and Postmenopausal Women

OriginalPaper

Variants of the VDR gene and Risk of Colon Cancer (United States)

OriginalPaper

The Heterogeneity in Risk Factors of Lung Cancer and the Difference of Histologic Distribution between Genders in Taiwan

OriginalPaper

Prospective Study of Antibody to Human Papilloma Virus type 16 and Risk of Cervical, Endometrial, and Ovarian Cancers (United States)

Note

Tobacco Litigation: A Mid-Course Review

OriginalPaper

Evaluating the Impact of Population Changes in Diet, Physical Activity, and Weight Status on Population Risk for Colon Cancer (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits